EP Patent

EP4719360A1 — Solid elacestrant dihydrochloride compositions, methods of making the same, and methods of treatment using the same

Assigned to Berlin Chemie AG · Expires 2026-04-08 · 0y expired

What this patent protects

Solid pharmaceutical compositions of elacestrant dihydrochloride with high hardness values increase the dissolution time for elacestrant. Methods of making solid pharmaceutical elacestrant dihydrochloride compositions are disclosed, in which a mixture comprising elacestrant dihyd…

USPTO Abstract

Solid pharmaceutical compositions of elacestrant dihydrochloride with high hardness values increase the dissolution time for elacestrant. Methods of making solid pharmaceutical elacestrant dihydrochloride compositions are disclosed, in which a mixture comprising elacestrant dihydrochloride and one or more pharmaceutically acceptable excipients is compressed at a pressure of at least 1 kN to produce a tablet with high hardness and a favorable dissolution profile. Methods of treatment for breast cancer include administering the solid pharmaceutical composition to a human subject.

Drugs covered by this patent

Patent Metadata

Patent number
EP4719360A1
Jurisdiction
EP
Classification
Expires
2026-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Berlin Chemie AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.